Features- Mar 12, 2021
At least one person died of blood clots after receiving AstraZeneca's COVID-19 vaccine. Several countries halted the use of this vaccine quickly.
Features- Jan 19, 2021
Norway has launched an investigation to look into the death of 23 elderly patients who died after getting the Pfizer-BioNTech mRNA COVID-19 vaccine.
Features- Dec 22, 2020
The survey was conducted in 242 districts around the country with more than 18,000 participants from October 15 and 20 by LocalCircles.
Features- Dec 21, 2020
According to the country’s government officials, New Zealand has already purchased COVID-19 vaccines from AstraZeneca and Novavax.
Features- Dec 15, 2020
After Tamil Nadu and Madhya Pradesh, Kerala is the latest state in India to announce that it would offer its people free COVID-19 vaccines.
Features- Dec 11, 2020
Russian officials had warned that citizens, after receiving the Sputnik V vaccine, should refrain from drinking alcohol for two months.
Mobile - Jul 28, 2023
Features - Mar 19, 2021
Review - Mar 19, 2021
Gadgets - Mar 19, 2021
Features - Mar 18, 2021
Review - Mar 18, 2021
Features- Dec 09, 2020
90-year-old Margaret Keenan received the first of the two shots of the COVID-19 vaccine at University Hospital, Coventry right ahead of her birthday.
Multiple vendors were found selling doses of the Pfizer COVID-19 vaccine on the darknet to global customers. A piece reportedly cost $1,300.
Features- Dec 08, 2020
PM Modi also said the administration of the COVID-19 vaccine to selected groups would start as soon as the scientists developing it said it was ready
Features- Dec 04, 2020
The vaccine will be rolled out next week. The UK has placed orders for enough doses of the two-shot vaccine to vaccinate 20 million citizens.
Features- Dec 02, 2020
From the data of its Phase III trial, Moderna has discovered that its vaccine could 100% prevent severe cases of COVID-19.
Features- Nov 30, 2020
The United Kingdom is set to approve the COVID-19 vaccine developed by Pfizer and BioNTech SE next week, according to the Financial Times.